National Bank Of Canada Exact Sciences Corp Transaction History
National Bank Of Canada
- $73.7 Billion
- Q4 2024
A detailed history of National Bank Of Canada transactions in Exact Sciences Corp stock. As of the latest transaction made, National Bank Of Canada holds 837 shares of EXAS stock, worth $41,272. This represents 0.0% of its overall portfolio holdings.
Number of Shares
837
Previous 780
7.31%
Holding current value
$41,272
Previous $53,000
11.32%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding EXAS
# of Institutions
677Shares Held
164MCall Options Held
4.3MPut Options Held
1.94M-
Capital World Investors Los Angeles, CA17.5MShares$865 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA17MShares$839 Million0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$595 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.1MShares$595 Million0.13% of portfolio
-
State Street Corp Boston, MA6.23MShares$307 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $8.73B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...